High <scp>MAF</scp> of <scp> <i>EGFR</i> </scp> mutations and high ratio of <scp>T790M sensitizing mutations</scp> in <scp>ctDNA</scp> predict better third‐generation <scp>TKI</scp> outcomes
Thoracic cancer